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This methodological study adapted and analyzed the psychometric properties of the 
Measurement of Treatment Adherence (MTA) instrument for Brazilian users of oral 
anticoagulation therapy. Its final version was tested with 178 individuals. The average 
of answers for all questions ranged from 4.6 to 5.8 and 97.2% of the individuals were 
considered adherent. Moderate correlations were obtained between the adherence measure 
and the Mental health and Vitality domains of the SF-36. Cronbach’s alpha was 0.60 and 
the ceiling effect occurred in answers to all items. These results indicate weak evidence 
of the validity, reliability and responsiveness of the MTA-adapted version for users of oral 
anticoagulant therapy.
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Adaptação e validação de uma medida de adesão à terapia de 
anticoagulação oral
Este é um estudo metodológico que teve como objetivos adaptar e analisar as propriedades 
psicométricas do instrumento medida de adesão aos tratamentos (MAT) como medida 
de adesão à terapêutica de anticoagulação oral (ACO). A versão final foi testada em 
178 sujeitos. As médias das respostas aos itens do MAT variaram de 4,6 a 5,8, sendo 
que 97,2% foram considerados aderentes. Correlações moderadas foram obtidas entre 
a medida de adesão e os domínios saúde mental e vitalidade, do SF-36. O alfa de 
Cronbach obtido foi 0,60 e constatou-se a presença de efeito máximo nas respostas de 
todos os itens. Esses resultados indicam fracas evidências da validade, confiabilidade e 
responsividade da versão adaptada do MAT para usuários de anticoagulantes orais.
Descritores: Estudos de Validação; Psicometria; Anticoagulantes; Questionários; Adesão 
ao Medicamento.
Adaptación y validación de una medida de adhesión a la terapia de 
anticoagulante oral
Este es un estudio metodológico que tuvo como objetivos adaptar y analizar las 
propiedades psicométricas del instrumento medida de adhesión a los tratamientos (MAT) 
como medida de adhesión a la terapéutica de anticoagulante oral (ACO). La versión 
final fue probada en 178 sujetos. Los promedios de las respuestas a los ítems del MAT 
variaron de 4,6 la 5,8, siendo que 97,2% fueron considerados adherentes. Correlaciones 
moderadas fueron obtenidas entre la medida de adhesión y los dominios salud mental 
y vitalidad, del SF-36. El alfa de Cronbach obtenido fue 0,60 y se constató la presencia 
de efecto máximo en las respuestas de todos los ítems. Eses resultados indican débiles 
evidencias de la validad, confiabilidad y responsividad de la versión adaptada del MAT 
para usuarios de anticoagulantes orales.
Descriptores: Estudios de Validación; Psicometría; Anticoagulantes; Cuestionario; 
Adhesión al Tratamiento.
Introduction
Adherence can be defined as the level of agreement 
between the recommendations of the healthcare provider 
and the individual’s behavior in relation to the therapeutic 
regimen(1). There are several factors influencing non-
adherence to the pharmacological treatment, such as: 
factors related to the patient, disease, treatment, health 
services and social support(2). Brazilian research on the 
subject related to medication adherence is common 
among individuals using antiretroviral, anti-hypertensive 
and anti-diabetic (hypoglycemic) medications, however, 
it is incipient among individuals using oral anticoagulant 
therapy (OAT). Adherence to OAT is one of the important 
factors in achieving an optimum level of anticoagulation 
in order to avoid bleeding and thromboembolic 
complications among patients. Additionally, its misuse - 
under-dosing or overdosing - whether by forgetfulness 
or human error, can also pose risk to health, increasing 
the chances of bleeding or thromboembolic events, since 
the therapy goals are not being met(3).
Research addressing the management of OAT has 
indicated some factors that can affect the control of this 
therapy, such as: clinical factors (e.g. acute disease, 
drug interactions, changes in diet), genetic factors 
and psychosocial factors (e.g. depression, cognitive 
disorder and one’s perceived health condition)(3). There 
are practical and psychological requirements for OAT 
to be successful. These requirements may positively or 
negatively affect an individual’s perception of health and 
quality of health(4).
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The potential effects of inadequate adherence to 
OAT and risk factors that influence treatment adherence 
among patients are known, however, these effects and 
the best methods to evaluate them have not been well 
elucidated(3).
One of the difficulties found by researchers in 
evaluating medication adherence is the lack of valid, 
reliable, user-friendly and low-cost instruments in 
Brazil and worldwide, which hinders the comparison of 
results of different therapies and between distinct health 
services.
The best known and most used instrument for 
evaluating medication adherence is the Moriski-
Green questionnaire(5-6). Another proposed adherence 
instrument is the Measurement of Treatment Adherence(1) 
(MTA), which was elaborated and tested among 
Portuguese diabetics and hypertensive individuals(1). It 
was already validated in Brazil among a population of 
diabetic individuals and obtained satisfactory results(7). 
This study aimed to adapt and analyze the psychometric 
proprieties of the MTA instrument for Brazilians 
undergoing oral anticoagulant therapy concerning the 
instrument’s validity (face, content and construct), 
reliability (internal consistency) and responsiveness in 
detecting changes.
Casuistic and Method
Design, casuistic and ethical aspects
This is a methodological study to adapt and validate 
the MTA(1) instrument, in a sample of anticoagulated 
individuals in Brazil. It was initiated after consent of the 
authors of the original version of the instrument was 
obtained. For its adaptation and validation, the original 
instrument was evaluated in terms of face and content 
validity by an expert committee and submitted to semantic 
analysis by individuals using OAT. The adapted version 
was tested on 178 individuals randomly approached 
while they were waiting for their appointment at the oral 
anticoagulation outpatient facility of a school hospital 
in the interior of São Paulo state, Brazil. The following 
inclusion criteria were considered: being 18 years old 
or older; following-up at the outpatient due to the use 
of OAT regardless of duration of use; showing cognitive 
ability to answer the instrument’s questions. The project 
was approved by the Research Ethics Committee at the 
institution and authorization to access the patients’ files 
was granted. All the individuals who agreed to participate 
in the study signed a free and informed consent form.
Data Collection
The individuals answered the MTA(1) instrument 
adapted for Brazilians using oral anticoagulation and 
the Medical Outcomes Study 36 - Item Short-Form 
Health Survey(8) (SF-36) adapted to Portuguese(9). The 
individuals’ sociodemographic and clinical data were 
collected through individual interviews and consulting 
their medical files.
Instruments: Measurement of Treatment 
Adherence (MTA)
MTA is composed of seven items that evaluate 
the individuals’ behavior in relation to the daily use 
of medication(1), while some items were adapted from 
other authors (Items 1, 2, 3 and 4(5), Item 6(10) and Item 
7(11)). Answers were obtained using a six-point ordinal 
scale varying from always (1) to never (6). The scores 
obtained with answers to the seven items are summed 
and divided by the number of items, varying from one 
to six. Afterwards, the values 5 and 6 are computed 
as one (which in the original scale corresponds to 
adherence) and the remaining are computed as zero 
(non-adherence) ending up with a dichotomous scale: 
adherent/non-adherent.
Medical Outcomes Survey Short Form 36-items (SF-36)
This multidimensional questionnaire evaluates an 
individual’s perceived health status and is composed 
of 36 items that cover eight components or domains: 
Physical functioning (10 items), Role physical (four), 
Bodily pain (two), General health (five), Vitality (four), 
Social functioning (two), Role emotional (three), Mental 
health (five) and another question to compare the 
evaluation of current health status with that of one year 
ago. The scores of each of the domains are normalized 
on a scale from 0 to 100, in which low numbers 
indicate worse perceived health status(8). The SF-36 
evaluates the individual’s perception of disease and/or 
treatment in various aspects of life and has been used 
in the investigation of individuals in oral anticoagulation 
treatment(3-4).
MTA Adaptation and validation process
The original version was submitted to face and 
content validity by a committee of experts and to 
semantic analysis by seven individuals using OAT. The 
experts (four nurses and one physician, all experts in 
cardiology) were asked to evaluate the relevance and 
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clarity of each item so that each would meet the study’s 
objectives. The experts made semantic adaptations from 
the Portuguese of Portugal to Brazilian Portuguese, so 
the instrument’s use would be appropriate to Brazilian 
individuals. This version was submitted to semantic 
analysis, which revealed to the authors that the patients’ 
answers concerned medication used, not specifically 
focusing on the OAT. When patients were asked about it, 
they confirmed that the MTA questions did not lead them to 
focus on their oral anticoagulation therapy only, but on all 
medication they were using. Thus, the researchers changed 
the wording of questions and adapted them to users of oral 
anticoagulant therapy, replacing the word medication with 
oral coagulant and adding some information related to OAT 
such as in questions 4, 5 and 7, with a view to clarify for 
individuals the potential complications related to the use of 
OAT (e.g. increased menstrual flow, bruises, blood in urine 
or feces, bleeding gums) and also related to reasons that 
could lead them not to take the medication (not having 
the medication at home or at another place, not having 
money, running out of medication or not being able to 
buy the medication or, the medication is not available at 
the drugstore or at the basic health unit). These changes 
aimed to clarify the MTA items to patients using OAT. The 
scale was not altered since it was considered appropriate 
both by the judges and participants, thus the original 
version(1) was maintained.
Data analysis
We assumed strong and moderate correlations 
between adherence measures (MTA) and health status 
(SF-36) in order to analyze the convergent construct 
validity. Spearman’s correlation test was performed and 
the results were analyzed according to the following 
classification: scores below 0.30 have little clinical 
applicability even when statistically significant, scores 
between 0.30 and 0.50 are moderate and above 0.50 
have a strong magnitude(12). The level of significance 
adopted in this study was 0.05. The instrument reliability 
evaluated through the internal consistency of the MTA 
items was verified by Crombach’s alpha, considering 
appropriate scores between 0.70 and 0.90(13). It is worth 
noting that some high alpha values are usually found 
in scales with many items due to the fact the alpha 
depends on the number of items in the scale. This same 
dependency can happen with instruments with few 
items, such as MTA. In this case, an alpha value around 
0.50 is acceptable(14). The instrument’s responsiveness 
was verified with the presence of ceiling and floor effects 
in the studied samples. An instrument responsiveness 
test reports its capacity to detect changes, for example, 
when the individual improves or worsens(15); it refers 
to the instrument’s ability to detect clinically important 
changes over time(16). The ceiling and floor effects are 
taken into account when respondents chose the highest 
or lowest scores, respectively, in the scale. Hence, if 
these effects are present it is likely that answers are 
at the beginning or at the end of the scale, which 
indicates limited content validity. As a consequence, 
individuals with the lowest or the highest scores cannot 
be discriminated and the instrument responsiveness is 
reduced. The floor effect (low adherence) was considered 
when more than 15% of respondents opted for answer 
number 1 and the ceiling effect when more than 15% 
opted for the answer with score 6(16).
Results
Among the 178 participants, 116 (65.3%) were 
women. The average age was 55.6 years (interval from 
24.8 to 86.1), 60% of them were younger than 60 years 
old. The majority reported not completing primary school 
(126 – 70.8%), average family income was R$ 896* 
(interval from R$ 300 to R$ 4,500), married/consensual 
union (118 – 65.2%), white (115 – 63.9%), retired (65 – 
36.7%), from Ribeirão Preto and other cities in the state 
of São Paulo, Brazil (148 – 83.2%). The main indications 
for the use of OAT were: artificial heart valve (50.6%) 
and atrial fibrillation (33.1%), followed by thrombus 
in the ventricle (8.4%), pulmonary thromboembolism 
(2.2%), stroke (2.2%), acute myocardial infarction 
(1.1%), pacemaker (1.1%) and deep vein thrombosis 
(0.6%). The participants also used other medications 
such as: anti-hypertensives (116 – 65.2%), diuretics (99 
– 55.6%), beta blockers (74 – 43.7%), followed by other 
groups of medications (127 – 71.3%). In relation to the 
number of medications, 85 (49.4%) of the individuals 
used from three to five medications, 43 (25%) used up 
to two medications and 44 (25.6%) participants used 
six or more, varying from one to 12, with an average 
of four medications per individual. This information was 
not available in the medical files of six participants.
In relation to the descriptive analysis of the 
MTA adapted version, the total scale and each one 
of the items, an average value of 5.5 (sd=0.45) was 
obtained for the total measure and average values 
between 4.6 and 5.9 for the items. We observe 
that six of the seven items presented a median of 
six, which corresponds to the score related to the 
answer “Never”, though the scores intervals also 
*
 N.T. ~ USD 509 in March 2010.
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comprehended lower scores, that is, the scores one 
and two (Table 1). The obtained answers were summed 
and the values divided by the instrument’s number 
of items (possible interval from 1 to 6). Afterwards, 
the scores 5 and 6 were computed as one (which in 
the original scale corresponds to adherent) and the 
remaining ones were computed as zero (non-adherent 
in the original scale). After this categorization, 173 
(97.2%) individuals were classified as adherent and 
only five (2.8%) as non-adherent.
MTA adapted version Average (sd) Median
Obtained 
Interval
Total scale 5.5 (0.4) 5.7 3.4 - 6
Items
How often did you forget to take the anticoagulant? 5.3 (0. 9) 6 1-6
How often did you take the anticoagulant outside of the scheduled time? 4.6 (1.6) 5 1-6
How often did you stop taking the anticoagulant because you felt better? 5.9 (0.5) 6 2-6
How often did you stop taking the anticoagulant because you felt worse? 5.7 (0.8) 6 1-6
How often did you change the anticoagulant dose because you forgot to take it the day before? 5.8 (0.6) 6 1-6
How often did you not take the anticoagulant because you ran out of it? 5.7 (0.7) 6 2-6
How often did you not take the anticoagulant for reasons beyond your control? 5.8 (0.5) 6 4-6
Questions Always
Almost 
always
Frequently Sometimes Rarely Never
How often did you forget to take the anticoagulant? 0.6% 0.6% 1.1% 16.3% 27.5% 53.9%
How often did you take the anticoagulant out of the scheduled time? 10.1% 4.5% 2.8% 21.9% 23% 37.6%
How often did you stop taking the anticoagulant because you felt 
better?
- 0.6% 1.1% 1.7% 2.2% 94.4%
How often did you stop taking the anticoagulant because you felt 
worse?
1.1% 0.6% - 7.3% 4.5% 86.5%
How often did you change the anticoagulant dose because you forgot 
to take it the day before?
0.6% 1.1% - 1.7% 3.9% 92.7%
How often did you not take the anticoagulant because you ran out of it? - 1.1% - 5.1% 14% 79.8%
How often did you not take the anticoagulant for reasons beyond 
your control?
- - - 3.4% 10.1% 86.5%
Table 1 – Descriptive analysis of the adapted version of the MTA instrument in 178 patients undergoing oral 
coagulation treatment.
The descriptive analysis of items permitted 
evaluating the responsiveness of the MTA adapted version 
among individuals using OAT, verified by the presence of 
ceiling and floor effects in the studied sample. As the 
medians of the participants’ answers indicated (Table 1), 
we observe in Table 2 that the frequencies of answers 
for each question of the instrument are above 15% for 
the answer “Never” (score six), which corresponds to 
the best evaluation for adherence (ceiling effect). The 
highest frequency of this answer is found in the question 
How often did you stop taking the anticoagulant because 
you felt better? (92.7%) and the lowest was found in the 
question How often did you take the anticoagulant out of 
the scheduled time? (37.6%).
Table 2 – Distribution of the percentage of answers to questions of the MTA adapted version, of 178 patients 
undergoing oral coagulant therapy.
The validity of the convergent construct was 
verified by the correlation of the adherence measure 
with the measures of the SF-36 domains. Both scales 
are ordered in such a way that higher scores indicate a 
higher level adherence and better evaluation of perceive 
health status. The Spearman’s correlation coefficients 
between measures are presented in Table 3. Moderate 
and statistically significant correlations were observed 
only between the adherence measure and the domains 
of Mental health (r=0,318; p<0.001) and Vitality 
(r=0.305; p<0.001). Although statistically significant, 
the correlations of adherence with the domains of Bodily 
pain, General Health and Social functioning were below 
0.30 and of no clinical relevance.
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Table 3 – Spearman’s correlation coefficients between 
adherence measures (MTA) and general health status 
(SF-36 domains) according to the answers of 178 
patients undergoing oral anticoagulant therapy.
SF-36 Domains r p
Mental Health 0.318 <0.001
Vitality 0.305 <0.001
Bodily pain 0.198 <0.05
General health 0.164 <0.05
Social functioning 0.164 <0.05
Role emotional 0.121 >0.05
Physical capacity 0.102 >0.05
Role physical 0.078 >0.05
Cronbach’s alpha value concerning the reliability 
of the MTA adapted version was 0.60. This value 
varies downward when each item of the instrument is 
drawn, varying from α=0.47 (when the first question 
is deleted) to α=0.59 (when questions 2 and 4 are 
deleted). The correlations of each item with the total 
scale (without the correlated item) were moderate for 
the MAT questions, except for the question 4, whose 
value was 0.11 (Table 4).
Table 4 – Analysis of the reliability of the MAT 
adapted version for the 178 patients undergoing oral 
coagulation therapy.
Item-total 
Correlation
Cronbach’s 
alpha when 
item was 
excluded 
Q1. How often did you forget to take the 
anticoagulant?
0.43 0.47
Q2. How often did you take the 
anticoagulant out of the schedule time?
0.32 0.59
Q3. How often you did you stop taking 
the anticoagulant because you felt 
better?
0.35 0.52
Q4. How often did you stop taking the 
anticoagulant because you felt worse?
0.11 0.59
Q5. How often did you change the 
anticoagulant dose because you had 
forgot to take it the day before?
0.32 0.52
Q6. How often did you not take the 
anticoagulant because you run out of it?
0.48 0.47
Q7. How often did you not take the 
anticoagulant for reasons beyond your 
control? 
0.34 0.53
Discussion
This study adapted the Measurement of Treatment 
Adherence for oral coagulant users and tested its 
validity (face, content and construct), reliability and 
responsiveness. As in the original study(1) and in the study 
of adaptation of the instrument for Brazil(7), patients who 
participated in the validation of the instrument in this 
study were predominantly adult, women, with low level 
of education, and used multiple medications to treat 
chronic conditions.
The items composing the MTA were considered 
relevant for the evaluation of OAT adherence considering 
the face and content validity of the adapted instrument 
evaluated by the judges. This judgment reinforces the 
proposal of authors(1) to enlarge the original measure 
of four items(5) including questions that address non-
adherence behaviors due to excess of prescriptions 
(Item 5), situations that can lead to the interruption 
of the treatment due to economic reasons or other 
reasons (Item 6) and reasons that lead to the treatment 
interruption other than medical indications (Item 7).
In regard to the results of the adapted instrument for 
OAT, an average of 5.5 (sd=0.4) was found for the total 
of seven items with an interval of 3.4 to 6. These results 
were similar to those obtained in the original version(1). 
The evaluation of the convergent construct validity of 
the MTA adapted version between individuals using the 
OAT was verified by the correlation of the adherence 
measure with the measures of the SF-36 domains and 
presented statistically significant moderated correlations 
only between the adherence measure and the mental 
health and vitality domains. No other authors evaluated 
the validity of the MTA construct using this measure 
of perceived health status. The validity of concurrent 
criterion has been used associating the adherence 
measure evaluated by the Likert scale for the seven 
MTA items with counting of medications(1). This validity 
was not investigated in this study due to the difficulty 
of counting the medications among patients cared 
for in the outpatient clinic. Return visits could not be 
scheduled due to a lack of time for patients to bring their 
medications to be counted by the researchers.
The instrument’s internal consistency measured 
by Cronbach’s alpha was 0.6, a value that can be 
considered appropriate given the instrument’s small 
number of items(14). This value is similar to those found 
in studies that use adherence measures of four items(5) 
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and dichotomous items(17), which obtained alpha values 
of 0.61 and 0.54 respectively. We observe that the 
inclusion of another item, even a dichotomous one, 
raised the alpha value to 0.71 in another study(11), which 
did not occur when the MTA with seven items were tested 
with dichotomous answers (alpha of 0.54)(1). Hence, we 
considered that the value 0.60 obtained in the seven-
item version did not achieve the result obtained in the 
original MTA version using the Likert scale (alpha of 
0.74) but was a little higher than that obtained with the 
dichotomous response scale. When the alpha value was 
tested in the original study(1), considering the successive 
withdrawn of each one of the MTA items, amplitude 
from 0.69 to 0.73 was obtained, while amplitude from 
0.47 to 0.59 was found in this study. The values of the 
correlations between item-total also differed in the two 
studies: 0.11 to 0.48 for individuals using OAT and 0.37 
to 0.56 for the Portuguese individuals(1).
The instrument responsiveness was tested by the 
presence of ceiling and floor effects and a percentage 
larger than 15% was obtained in all questions for the 
alternative “Never”, which corresponds to the largest 
score and highest adherence on the scale. Hence, 
evidence of the ceiling effect suggests that the instrument 
does not allow detecting changes in individuals in 
relation to OAT adherence(16). Studies that evaluated the 
responsiveness through the presence of these effects 
were not found either. According to the instrument, 
97.2% of the individuals were classified as adherent 
to their OAT. The percentage of adherence was higher 
than the results described in the Portuguese study(1) 
and by those who tested the instrument in Brazil(7), 
61.6% and 78.3% respectively. Some hypotheses were 
considered to explain this higher percentage such as the 
inexistence of side effects such as those caused by anti-
hypertensive and oral hypoglecemiants, accounting for 
the difference in the results obtained in other studies(1,7). 
The low percentage of non-adherent individuals (2.8%) 
hindered comparison between the two groups to test the 
adapted version’s sensitivity so as to perceive differences 
between the groups.
This study presents weak evidence to confirm the 
psychometric properties of the instrument when adapted 
to individuals using OAT. However, given the results 
obtained by the original MTA version in other studies(1,7), 
we suggest further research to evaluate the construct 
validity, criterion, reliability and responsiveness of the 
version adapted for individuals using OAT, who present 
other sociodemographic profiles or higher educational or 
income levels.
Conclusions and Final Considerations
This initial study aimed to adapt the Measurement of 
Treatment Adherence instrument proposed as a general 
measure of pharmacological adherence exclusively in 
regard to the use of oral anticoagulant therapy. The 
results obtained were sufficient to confirm the validity 
and reliability of the adapted version when used for 
individuals using this therapy. We suggest further 
research with patients with diversified sociodemographic 
and clinical characteristics using oral anticoagulant 
therapy as well as further research concomitantly using 
other adherence measures such as the counting of 
medications, electronic monitoring and other self-report 
instruments.
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